Introducing The Hypertrophic Cardiomyopathy Center
Hypertrophic Cardiomyopathy (HCM) is an extremely common condition affecting at least 1 in 500 Americans. This condition can be diagnosed at any time from infancy to adulthood.
HCM patients have a genetic predisposition to an abnormal thickening of the heart muscle. In some patients, HCM may be silent, causing few or no symptoms. In others, symptoms vary widely, from mild chest pain and difficulty breathing to serious arrhythmias, conduction problems, and heart failure.
The NewYork-Presbyterian HCM Center has the depth and breadth of experience to provide seamless care for these patients and their families, at every age, and at every stage of this disease.
Our multidisciplinary team creates a comprehensive and individualized approach for each patient. We also screen and assess first-degree relatives for HCM-related genes.
Nationally known for our expertise in heart failure, genetics, noninvasive imaging, interventional techniques, cardiac surgery, and heart transplantation, The HCM Center at NYP/Columbia offers patients the full spectrum of treatment options.
A collaborative, cross-specialty approach results in a high level of integrated care, as well as an exceptional continuity of care.
At present, there are only a few centers in the U.S. specializing in HCM. Our goal is to provide comprehensive and compassionate patient-centered treatment, along with cutting edge medical and surgical care for patients and families with HCM.
While offering the broadest range of treatment options, we will also engage in leading-edge research to help us better understand and manage this condition.
Mathew Maurer, MD
Hiroo Takayama, MD, PhD
Co-Directors of The HCM Center at NewYork-Presbyterian/Columbia